Know Cancer

or
forgot password
  • cancer clinical trials in connecticut

  • Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Manchester Memorial Hospital

    Trial Locations
    Manchester Memorial Hospital
    Norwalk Hospital
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
    Oncology Associates of Bridgeport
    Trumball, Connecticut 06611
    Peripheral T-cell Lymphoma
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
    Connecticut Children's Medical Center
    Hartford, Connecticut 06106
    Leukemia
    Strategic Timing of Antiretroviral Treatment
    Yale University School Of Medicine
    New Haven, Connecticut 06520
    HIV Infection
    Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Liver Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center

    Trial Locations
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Manchester Memorial Hospital
    Middlesex Hospital Cancer Center
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Breast Cancer, Lung Cancer, Metastatic Cancer, Multiple Myeloma, Plasma Cell Neoplasm, Prostate Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study
    Teva Investigational Site 70

    Trial Locations
    Teva Investigational Site 70
    Teva Investigational Site 37
    Teva Investigational Site 67
    Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma
    Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy
    Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
    Hartford, Connecticut 06105
    Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Saint Vincent's Medical Center

    Trial Locations
    Saint Vincent's Medical Center
    Hartford Hospital
    The Hospital of Central Connecticut
    Yale University
    William Backus Hospital
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    The Hospital of Central Connecticut
    New Britain, Connecticut 06050
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
    Hartford Hospital

    Trial Locations
    Hartford Hospital
    The Hospital of Central Connecticut
    Atypical Endocervical Glandular Cell of Undetermined Significance, Atypical Endometrial Hyperplasia, Atypical Glandular Cell of Undetermined Significance, Cervical Cancer, Cervical Intraepithelial Neoplasia Grade 2, Cervical Intraepithelial Neoplasia Grade 3, Human Papilloma Virus Infection
    Collecting Tumor Samples From Patients With Gynecological Tumors
    Praxair Cancer Center at Danbury Hospital

    Trial Locations
    Praxair Cancer Center at Danbury Hospital
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    Yale Cancer Center
    Cancer
    Study of Kidney Tumors in Young Patients
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale Cancer Center
    Kidney Cancer, Nonneoplastic Condition
    Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
    Helen and Harry Gray Cancer Center at Hartford Hospital
    Hartford, Connecticut 06102-5037
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale Cancer Center
    Sarcoma
    Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale Cancer Center
    Neuroblastoma
    Optical Tomography With Ultrasound Guidance
    Hartford Hospital
    Hartford, Connecticut 06102-5037
    Breast Cancer
    Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
    The Hospital of Central Connecticut

    Trial Locations
    The Hospital of Central Connecticut
    Cancer Center of Central Connecticut
    B-Cell Chronic Lymphocytic Leukemia (B-CLL)
    Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer
    Pfizer Investigational Site
    Farmington, Connecticut 06030-3805
    Breast Cancer, Advanced Breast Cancer
    Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer
    Eastern Connecticut Hematology Oncology
    Norwich, Connecticut 06360
    Metastatic Breast Cancer
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    Connecticut Children's Medical Center

    Trial Locations
    Connecticut Children's Medical Center
    Yale University
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
    Hematology Oncology PC
    Stamford, Connecticut 06902
    Metastatic Breast Cancer